RÉSUMÉ
BACKGROUND: The landscape of polyarteritis nodosa (PAN) has substantially changed during the last decades. Recent data regarding causes, characteristics, and prognosis of systemic PAN in the modern era are lacking. METHODS: This retrospective study included patients with systemic PAN referred to the French Vasculitis Study Group between 2005 and 2019. Characteristics, associated conditions and outcomes were collected, and predictors of relapse and death were analyzed. RESULTS: 196 patients were included. Main clinical symptoms were constitutional (84%), neurological (59%), skin (58%) and musculoskeletal (58%) manifestations. Secondary PAN accounted for 55 (28%) patients, including myelodysplastic syndrome (9%), solid cancer (7%), lymphoma (4%) and autoinflammatory diseases (4%). No patient had active HBV infection. All treated patients (98.5%) received glucocorticoids (GCs), alone (41%) or in combination with immunosuppressants (59%), with remission achieved in 90%. Relapses were independently associated with age >65 years (HR 1.85; 95% CI1.12-3.08), gastrointestinal involvement (1.95; 95% CI1.09-3.52) and skin necrotic lesions (HR 1.95; 95%CI 1.24-3.05). One-, 5- and 10-year overall survival rates were 93%, 87% and 81%, respectively. In multivariate analyses, age >65 years (HR 2.80; 95%CI 1.23-6.37), necrotic purpura (HR 4.16; 95%CI 1.62-10.70), acute kidney injury (HR 4.89; 95% 1.71-13.99) and secondary PAN (HR 2.98; 95%CI 1.29-6.85) were independently associated with mortality. CONCLUSION: Landscape of PAN has changed during the last decades, with the disappearance of HBV-PAN and the emergence of secondary PAN. Relapse rate remains high, especially in aged patients with gastrointestinal and cutaneous necrosis, as well as mortality.
Sujet(s)
Polyartérite noueuse , Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Sujet âgé , Études rétrospectives , Polyartérite noueuse/diagnostic , Polyartérite noueuse/épidémiologie , Polyartérite noueuse/étiologie , Récidive , PronosticRÉSUMÉ
In response to the coronavirus disease 2019 pandemic, the coronavirus disease 2019 vaccine was rapidly developed and the effectiveness of the vaccine has been established. However, various adverse effects have been reported, including the development of autoimmune diseases. We report a case of new-onset polyarteritis nodosa in a 32-year-old male following the coronavirus disease 2019 vaccination. The patient developed limb pain, fever, pulmonary embolism, multiple subcutaneous nodules, and haematomas. Skin biopsy revealed necrotising inflammation accompanied by fibrinoid necrosis and high inflammatory cell infiltration in the walls of medium to small arteries. The symptoms resolved following corticosteroid treatment. Although it is difficult to prove a relationship between the vaccine and polyarteritis nodosa, similar cases have been reported and further reports and analyses are therefore necessary.
Sujet(s)
Vaccins contre la COVID-19 , COVID-19 , Polyartérite noueuse , Adulte , Humains , Mâle , Hormones corticosurrénaliennes , COVID-19/diagnostic , COVID-19/prévention et contrôle , COVID-19/complications , Vaccins contre la COVID-19/effets indésirables , Polyartérite noueuse/diagnostic , Polyartérite noueuse/étiologie , Peau/anatomopathologieRÉSUMÉ
Polyarteritis nodosa (PAN) is a primary form of vasculitis characterized by inflammation of primarily medium-sized arteries. Several key events have shaped the current spectrum of the disease including the separation of a subgroup with microscopic polyangiitis, the discovery of the association of hepatitis B, and the discovery of adenosine deaminase 2 deficiency (DADA2). With the discovery of secondary causes of PAN and changing nomenclature, the incidence of PAN has declined over time. Common manifestations include constitutional symptoms, skin involvement, peripheral neuropathy, gastrointestinal disease, and renal involvement. DADA2 is a genetic cause of medium vessel vasculitis that is important to distinguish from primary PAN as treatment with TNF inhibitors can prevent morbidity and mortality in those with a vasculitis phenotype. Treatment of systemic primary PAN involves the use of systemic immunosuppressive therapy largely guided by the severity of disease. With current treatment regimens, the prognosis has changed from a once uniformly fatal disease to a 5-year survival rate above 80%.
Sujet(s)
Polyartérite noueuse , Vascularite , Humains , Polyartérite noueuse/diagnostic , Polyartérite noueuse/traitement médicamenteux , Polyartérite noueuse/étiologie , Adenosine deaminase/génétique , Protéines et peptides de signalisation intercellulaire , Vascularite/complications , PronosticRÉSUMÉ
The global outbreak of coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus type 2 has prompted the rapid spread and development of vaccines to prevent the spread of the disease. COVID-19 vaccine has demonstrated excellent efficacy in reducing morbidity and severity of the disease, and most adverse reactions are very minor. However, some patients have been reported to develop autoimmune diseases, such as rheumatoid arthritis, myocarditis, Guillain-Barre syndrome, and vasculitis, following COVID-19 vaccination. Herein, we present a case of polyarteritis nodosa with epididymitis, following COVID-19 mRNA vaccination. The patient's initial symptoms were fever and testicular pain, and magnetic resonance imaging showed epididymitis. He was diagnosed as having polyarteritis nodosa with epididymitis and was treated with high-dose prednisolone, with a good clinical outcome.
Sujet(s)
Vaccins contre la COVID-19 , COVID-19 , Épididymite , Polyartérite noueuse , Humains , Mâle , COVID-19/diagnostic , COVID-19/prévention et contrôle , Vaccins contre la COVID-19/effets indésirables , Épididymite/diagnostic , Épididymite/étiologie , Polyartérite noueuse/diagnostic , Polyartérite noueuse/étiologie , VaccinationRÉSUMÉ
IgA vasculitis (IgAV) is the most frequent form of vasculitis in childhood which classically presents with purpura of the lower extremities, joint pain or swelling and abdominal pain. Though it is a self-limiting disease, and its prognosis is generally good, glomerulonephritis is one of the most important complications. IgAV is classified as a small vessel vasculitis, and though glomerulonephritis develops in IgAV, necrotizing arteritis is rarely seen. Here, we present a case of a 13-year-old girl with IgAV, glomerulonephritis, and necrotizing arteritis in the small renal arteries. There have been only a few reports of adult cases of IgAV with necrotizing arteritis in the kidneys, but there have been no pediatric cases. Some previous reports showed a high mortality rate and implied the possibility of overlap with other vasculitides. In the current report, a rare case of IgAV is described which exhibited necrotizing arteritis rather than overlap with another vasculitis, with a relatively typical clinical course for IgAV and laboratory tests.
Sujet(s)
Glomérulonéphrite/étiologie , /complications , Polyartérite noueuse/étiologie , Adolescent , Femelle , Glomérulonéphrite/anatomopathologie , Humains , Glomérule rénal/ultrastructure , Polyartérite noueuse/anatomopathologieRÉSUMÉ
The deficiency of adenosine deaminase 2 (DADA2) has recently been defined as a monogenetic autosomal recessive autoinflammatory disease. DADA2 is mainly characterized by high fever, livedo racemose, early-onset stroke, mild immunodeficiency and clinically polyarteritis nodosa (PAN)-like symptoms. Mutations in CECR1 (cat eye syndrome chromosome region, candidate 1) are responsible for DADA2. Livedoid racemose, lacunar infarct due to involvement in small vessel of the central nervous system, peripheral neuropathy, digital ulcers and loss of fingers are predominantly seen in the disease which could progress to end-stage organ failure and death in some patients. A wide spectrum of severity in phenotype as well as in the age of onset has been reported in the literature. This phenotypic variability is also found in our clinical practice even in patients with the same mutation. Here, we present a family diagnosed with DADA2, with the previously reported p.Gly47Arg mutation in CECR1.
Sujet(s)
Agammaglobulinémie/diagnostic , Polyartérite noueuse/étiologie , Immunodéficience combinée grave/diagnostic , Adolescent , Hormones corticosurrénaliennes/usage thérapeutique , Adulte , Agammaglobulinémie/complications , Agammaglobulinémie/traitement médicamenteux , Âge de début , Enfant , Enfant d'âge préscolaire , Famille , Femelle , Prédisposition génétique à une maladie , Humains , Immunosuppresseurs/usage thérapeutique , Mâle , Pedigree , Immunodéficience combinée grave/complications , Immunodéficience combinée grave/traitement médicamenteuxRÉSUMÉ
A 26-year-old male soldier was clinically characterized by transient fever, persistent right upper quadrant pain, hypertension, and elevated inflammatory biomarkers associated with bacterial infection. On the fifteenth day after the onset of symptoms, he had typical CT findings in polyarteritis nodosa involving only the hepatic arteries. Transcatheter arterial coil embolization of the right hepatic artery was performed due to ruptured hepatic aneurysms. Combination therapy with antibiotics and antihypertensives was administrated after embolization. The intrahepatic aneurysms completely vanished and inflammatory biomarkers returned to normal on the tenth day after embolization. The current case highlights the diagnosis and treatment of bacterial-infection-associated polyarteritis nodosa involving only the hepatic arteries, coexisting with hypertension.
Sujet(s)
Rupture d'anévrysme/étiologie , Infections bactériennes/complications , Artère hépatique , Polyartérite noueuse/étiologie , Adulte , Rupture d'anévrysme/imagerie diagnostique , Rupture d'anévrysme/thérapie , Antibactériens/usage thérapeutique , Antihypertenseurs/usage thérapeutique , Infections bactériennes/diagnostic , Infections bactériennes/traitement médicamenteux , Embolisation thérapeutique , Artère hépatique/imagerie diagnostique , Humains , Hypertension artérielle/traitement médicamenteux , Hypertension artérielle/étiologie , Mâle , Polyartérite noueuse/imagerie diagnostique , Polyartérite noueuse/thérapie , Résultat thérapeutiqueRÉSUMÉ
We present the case of a 67-year-old man in good health with perirenal hematoma due to a ruptured arterial aneurysm in the kidney. The patient developed weight loss, muscle weakness, multiple mononeuropathy, hypertension, anemia, renal insufficiency, and multiple lacuna infarctions about a month ago. He was admitted to the hospital due to worsening of his symptom. After admission, severe right-flank pain suddenly occurred; he was then transferred to our hospital. Renal angiography revealed bilateral multiple microaneurysms, and the patient was diagnosed with polyarteritis nodosa based on the clinical, radiographic, and histological findings. We performed selective coil embolization to the ruptured aneurysm and administered oral prednisolone along with intravenous methylprednisolone pulse therapy. Cyclophosphamide pulse therapy was also given. The treatment improved clinical and laboratory findings and achieved clinical remission. Selective coil embolization to the bleeding aneurysm of polyarteritis nodosa was minimally invasive and promptly effective. Immunosuppressants proved useful in the regulation of disease activity and the aneurysm.
Sujet(s)
Hématome/diagnostic , Maladies du rein/diagnostic , Polyartérite noueuse/diagnostic , Sujet âgé , Rupture d'anévrysme/complications , Hématome/étiologie , Humains , Maladies du rein/étiologie , Mâle , Polyartérite noueuse/étiologie , Artère rénaleRÉSUMÉ
We developed a questionnaire to examine the findings of cutaneous arteritis among dermatological specialists experienced in vasculitis as certified by the Committee for guidelines for the management of vasculitis and vascular disorders of the Japanese Dermatological Association. We sent a questionnaire to 12 dermatological facilities identified through the revised Committee for guidelines for the management of vasculitis and vascular disorders of the Japanese Dermatological Association. Retrospective data obtained from 84 patients at the 12 dermatological facilities between 2012 January 2016 December were evaluated. The 84 patients were categorized into two groups, a systemic steroid treatment group (group 1, n = 52) and a no systemic steroid treatment group (group 2, n = 32). C-reactive protein in group 1 patients was significantly higher than that in group 2 patients. Frequency of fever, arthritis, myalgia- and peripheral neuropathy in group 1 was significantly higher than that in group 2. We propose that these symptoms could serve as early markers for the transfer from cutaneous arteritis to systemic polyarteritis nodosa. We further suggest that patients who are subsequently associated with cerebral hemorrhage and infarction, who are originally diagnosed as having cutaneous arteritis, could progress to systemic polyarteritis nodosa. The study demonstrated that it is important for dermatologists to detect these findings early in order to establish an accurate diagnosis and a timely treatment.
Sujet(s)
Dermatologues/statistiques et données numériques , Polyartérite noueuse/étiologie , Peau/anatomopathologie , Adulte , Marqueurs biologiques/analyse , Protéine C-réactive/analyse , Femelle , Études de suivi , Glucocorticoïdes/usage thérapeutique , Humains , Japon , Mâle , Adulte d'âge moyen , Polyartérite noueuse/sang , Polyartérite noueuse/traitement médicamenteux , Polyartérite noueuse/anatomopathologie , Études rétrospectives , Peau/vascularisation , Enquêtes et questionnaires/statistiques et données numériquesRÉSUMÉ
Chronic progressive nephropathy (CPN) is the most commonly encountered spontaneous background finding in laboratory rodents. Various theories on its pathogenesis have been proposed, but there is a paucity of data regarding specific mechanisms or physiologic pathways involved in early CPN development. The current CPN mechanism of action for tumorigenesis is largely based on its associated increase in tubular cell proliferation without regard to preceding subcellular degenerative changes. Combing through the published literature from multiple biology disciplines provided insight into the preceding cellular events. Mechanistic pathways involved in the progressive age-related decline in rodent kidney function and several key inflexion points have been identified. These critical pathway factors were then connected using data from renal models from multiple rodent strains, other species, and mechanistic work in humans to form a cohesive picture of pathways and protein interactions. Abundant data linked similar renal pathologies to local events involving hypoxia (hypoxia-inducible factor 1α), altered intrarenal renin-angiotensin system (RAS), oxidative stress (nitric oxide), and pro-inflammatory pathways (transforming growth factor ß), with positive feedback loops and downstream effectors amplifying the injury and promoting scarring. Intrarenal RAS alterations seem to be central to all these events and may be critical to CPN development and progression.
Sujet(s)
Maladies du rein/étiologie , Système rénine-angiotensine/physiologie , Antagonistes du récepteur de type 1 de l'angiotensine-II/pharmacologie , Inhibiteurs de l'enzyme de conversion de l'angiotensine/pharmacologie , Animaux , Maladie chronique , Évolution de la maladie , Sous-unité alpha du facteur-1 induit par l'hypoxie/physiologie , Monoxyde d'azote/physiologie , Polyartérite noueuse/étiologie , RatsRÉSUMÉ
Polyarteritis nodosa is a progressive, often life-threatening, vasculitis affecting multiple organs, including the skin and peripheral nerves. We report a patient presenting with systemic features of the disease and with characteristic lesions in the feet 3 weeks after vaccination against hepatitis B virus infection.
Sujet(s)
Vaccins anti-hépatite B/effets indésirables , Hépatite B/prévention et contrôle , Polyartérite noueuse/étiologie , Lobe temporal/imagerie diagnostique , Adulte , Humains , Imagerie par résonance magnétique , Mâle , Polyartérite noueuse/diagnostic , Polyartérite noueuse/anatomopathologie , Lobe temporal/anatomopathologie , Orteils/anatomopathologieRÉSUMÉ
Çakan M, Aktay-Ayaz N, Karadag SG, Tahir-Turanli E, Stafstrom K, Bainter W, Geha RS, Chou J. Atypical phenotype of an old disease or typical phenotype of a new disease: deficiency of adenosine deaminase 2. Turk J Pediatr 2019; 61: 413-417. Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive autoinflammatory disorder caused by mutations in CECR1 (cat eye syndrome chromosome region, canditate 1) gene, which encodes the enzyme adenosine deaminase 2 necessary for endothelial cell survival and function. The diversity of the clinical phenotypes associated with DADA2 include polyarteritis nodosa-like vasculitic features, early-onset stroke, mild to severe immunodeficiency and cytopenias. The diagnosis of the disease may be difficult due to complex clinical phenotype. Herein, we present a case of DADA2 presenting with vasculitis, amarousis fugax, gastrointestinal bleeding and silent lacunar infarct successfully treated with etanercept.
Sujet(s)
Adenosine deaminase/déficit , Agammaglobulinémie/sang , Infarctus encéphalique/étiologie , Protéines et peptides de signalisation intercellulaire/déficit , Polyartérite noueuse/étiologie , Immunodéficience combinée grave/sang , Adenosine deaminase/sang , Adenosine deaminase/génétique , Adolescent , Infarctus encéphalique/diagnostic , Tronc cérébral/anatomopathologie , ADN/génétique , Analyse de mutations d'ADN , Humains , Protéines et peptides de signalisation intercellulaire/sang , Protéines et peptides de signalisation intercellulaire/génétique , Imagerie par résonance magnétique , Mâle , Mutation , Phénotype , Polyartérite noueuse/diagnosticRÉSUMÉ
The color purple can be seen in several types of eruptions including inflammatory dermatoses like lichen planus, infectious dermatoses like ecthyma gangrenosum, neoplasms like Kaposi sarcoma, and vasculitis and vasculopathy. The current review focuses on the clinical appearance, pathophysiology, and treatment of several vasculitides and vasculopathies including capillaritis, cutaneous small-vessel vasculitis, immunoglobulin A (IgA) vasculitis, cryoglobulinemia, granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis, microscopic polyangiitis, polyarteritis nodosum, warfarin-induced skin necrosis, heparin-induced thrombocytopenia, purpura fulminans, antiphospholipid antibody syndrome, calciphylaxis, levamisole-induced vasculopathy, and thrombotic thrombocytopenic purpura. Dermatologists play a central role in treating patients with cutaneous vasculitis and vasculopathy and may have the opportunity to facilitate identification of systemic disease by diagnosing cutaneous vasculitis and vasculopathy.
Sujet(s)
Peau/anatomopathologie , Vascularite/étiologie , Anticoagulants/effets indésirables , Syndrome des anticorps antiphospholipides/diagnostic , Syndrome des anticorps antiphospholipides/traitement médicamenteux , Syndrome des anticorps antiphospholipides/étiologie , Calciphylaxie/diagnostic , Calciphylaxie/étiologie , Calciphylaxie/thérapie , Syndrome de Churg-Strauss/diagnostic , Syndrome de Churg-Strauss/traitement médicamenteux , Syndrome de Churg-Strauss/étiologie , Couleur , Cryoglobulinémie/diagnostic , Cryoglobulinémie/traitement médicamenteux , Cryoglobulinémie/étiologie , Diagnostic différentiel , Granulomatose avec polyangéite/diagnostic , Granulomatose avec polyangéite/traitement médicamenteux , Granulomatose avec polyangéite/étiologie , Granulomatose avec polyangéite/anatomopathologie , Humains , Lévamisole/effets indésirables , Polyangéite microscopique/diagnostic , Polyangéite microscopique/traitement médicamenteux , Polyangéite microscopique/étiologie , Nécrose/induit chimiquement , Nécrose/diagnostic , Nécrose/thérapie , Polyartérite noueuse/diagnostic , Polyartérite noueuse/traitement médicamenteux , Polyartérite noueuse/étiologie , Purpura fulminans/diagnostic , Purpura fulminans/étiologie , Purpura fulminans/thérapie , Purpura thrombotique thrombocytopénique/diagnostic , Purpura thrombotique thrombocytopénique/étiologie , Purpura thrombotique thrombocytopénique/thérapie , Vascularite/diagnostic , Vascularite/thérapie , Warfarine/effets indésirablesRÉSUMÉ
Cogan's syndrome (CS) is defined by the combination of hearing loss, vertigo, and ocular inflammation of uncertain cause, and can be associated with variable vessel vasculitis. Vasculitic manifestations may include arteritis (affecting large, medium or small arteries), aortitis, and aortic and mitral valvulitis. Cutaneous manifestations including erythema, papules, subcutaneous nodules, and purpura sometimes occur; however, to date, only six cases have been histologically confirmed to have genuine vasculitis. Here, we report two cases of CS, one of which involved a patient who developed the typical symptoms of Takayasu arteritis and purpuric lesions in the legs, with histologic findings consistent with small vessel vaculitis in the dermis. The second case involved a patient who developed subcutaneous nodules in the legs and the axilla, and histologic findings revealed a necrotizing vasculitis of the small arteries in the interlobular area. Both cases were successfully treated with systemic steroid therapy. Based on the clinical features and the examination data, there is a possibility that a Chlamydia trachomatis infection played a pivotal role in the pathogenesis of those vasculitides.
Sujet(s)
Infections à Chlamydia/complications , Syndrome de Cogan/complications , Polyartérite noueuse/étiologie , Maladie de Takayashu/étiologie , Vascularite leucocytoclasique cutanée/étiologie , Adulte , Femelle , Humains , Jambe , Polyartérite noueuse/anatomopathologie , Peau/anatomopathologie , Maladie de Takayashu/anatomopathologie , Vascularite leucocytoclasique cutanée/anatomopathologieRÉSUMÉ
Polyarteritis nodosa is a systemic necrotizing vasculitis which predominantly affects medium-sized arteries. It is a rare disease nowadays. Both the nomenclature and the classification of polyarteritis nodosa was amended several times in the past. Currently, there is a distinction between the primary form described as classical polyarteritis nodosa and other forms that are associated with their probable cause e.g. with viral hepatitis B, C or HIV infection. Moreover, polyarteritis-like necrotizing vasculitis can appear in the course of genetic diseases caused by mutations in single genes. The pathogenesis of idiopathic polyarteritis nodosa is still unclear, but a dominant role of the adaptive immune system disorders is suggested. Interestingly, in the hepatitis B virus-related vasculitis development, immune complexes are believed to play a crucial role. The spectrum of clinical manifestations of polyarteritis nodosa is wide, from involving a single organ to the polyvisceral failure. In the course of polyarteritis nodosa nearly each organ can be involved, however the disease never affects the lungs. Special forms of polyarteritis nodosa include a single-organ disease and a cutaneous form. The diagnosis of polyarteritis nodosa requires integration of clinical, angiographic and biopsy findings. Recognizing the form of polyarteritis nodosa, determining affected organs and the progression of the disease is very important since those are deciding factors when choosing treatment strategies.
Sujet(s)
Mutation , Polyartérite noueuse/étiologie , Adulte , Femelle , Prédisposition génétique à une maladie , Infections à VIH/complications , Hépatite B/complications , Hépatite C/complications , Humains , Mâle , Adulte d'âge moyen , Polyartérite noueuse/diagnostic , Polyartérite noueuse/génétique , Polyartérite noueuse/thérapieRÉSUMÉ
Arteritis/polyarteritis occurs spontaneously in many species used in preclinical toxicology studies. In Göttingen minipigs, arteritis/polyarteritis is an occasionally observed background change. In the minipig, this finding differs in frequency and nature from age-related polyarteritis nodosa in rats or monkeys, and Beagle pain syndrome in dogs. In minipigs, it can be present in a single small- or medium-sized artery of an organ or a few organs and is most commonly recorded in the cardiac and extracardiac blood vessels, vagina, oviduct, rectum, epididymis, spinal cord, pancreas, urinary bladder, kidneys, and stomach. The etiology is unknown although it has been considered in minipigs as well as in rats, dogs, and monkeys to be possibly immune mediated. This background change is important with respect to its nature and distribution in the minipig in order to distinguish it from drug-induced vascular changes, which might occur in similar locations and have similar morphologic features. This review summarizes the morphology, incidence, and predilection sites of arteritis as a spontaneously occurring background change and as a drug-induced vasculopathy in the minipig, and also describes the main aspects to consider when evaluating vascular changes in Göttingen minipig toxicity studies and their human relevance.
Sujet(s)
Artérite/étiologie , Artérite/anatomopathologie , Animaux , Modèles animaux de maladie humaine , Polyartérite noueuse/étiologie , Polyartérite noueuse/anatomopathologie , Suidae , Porc miniatureSujet(s)
Adénocarcinome/chirurgie , Polyartérite noueuse/physiopathologie , Prostatectomie , Tumeurs de la prostate/chirurgie , Adénocarcinome/complications , Adénocarcinome/anatomopathologie , Sujet âgé , Humains , Mâle , Grading des tumeurs , Stadification tumorale , Polyartérite noueuse/étiologie , Tumeurs de la prostate/complications , Tumeurs de la prostate/anatomopathologieRÉSUMÉ
Cutaneous vasculitis, inflammatory destruction of blood vessels, can present with a wide range of clinical and pathologic findings across a number of heterogeneous conditions. Although some vasculitides are present in both children and adults, some important differences exist in clinical presentation, etiology, management, and prognosis in childhood vasculitis versus adult vasculitis. Cutaneous vasculitis is rare in children, and most childhood vasculitides, of which Henoch-Schönlein purpura is the most common, histologically are small vessel leukocytoclastic vasculitis. In children, infectious etiologies are more common than in adults. Childhood cutaneous vasculitis is most often self-limited with a good prognosis, and treatment is mainly supportive. © 2017 Elsevier Inc. All rights reserved.